Background The effects of pharmacological blood pressure lowering at normal or high-normal
blood pressure ranges in people with or without pre-existing cardiovascular disease …

… , Folkert W Asselbergs consultant cardiologist4547101, Naveed Sattar professor of metabolic
medicine102, Debbie A Lawlor professor of epidemiology5, John Whittaker professor and …

Approaches exploiting trait distribution extremes may be used to identify loci associated
with common traits, but it is unknown whether these loci are generalizable to the broader …

Background Statins increase the risk of new-onset type 2 diabetes mellitus. We aimed to
assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3-methylglutaryl…

Aims To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and
triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian …

Background— Microalbuminuria is associated with increased risk of cardiovascular events.
We assessed whether therapeutic intervention aimed at lowering urinary albumin excretion …

Height is a highly heritable, classic polygenic trait with approximately 700 common associated
variants identified through genome-wide association studies so far. Here, we report 83 …

BACKGROUND: Renal impairment is associated with increased mortality in heart failure (HF).
Recently, reports suggest that worsening renal function (WRF) is another predictor of …

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. A small proportion
of HF cases are attributable to monogenic cardiomyopathies and existing genome-wide …

Background It is unknown whether patients undergoing primary percutaneous coronary
intervention (PCI) benefit from genotype-guided selection of oral P2Y 12 inhibitors. Methods We …